Five structurally diverse small ligands, all binding to the major urinary protein (MUP) of the male house mouse, show individually puberty-accelerating pheromonal activity in the recipient females. A recombinant MUP (identical structurally to the natural protein) has shown no biological activity. While four of these ligands were previously implicated in oestrus synchronization (Whitten e¡ect), the same chemosignals now appear responsible for both sexual maturation and cycling in adult females.
INTRODUCTION
There is considerable evidence that chemical communication is involved in the regulation of sexual maturation in female rodents, with the house mouse (Mus domesticus) being the best physiologically documented case. Since the early 1960s, when the oestrus synchrony (Whitten 1958) of grouped female mice was observed (Marsden & Bronson 1964) following their exposure to male urine, numerous e¡orts were made to elucidate the nature of the male-originated pheromone(s) responsible for either the advancement of puberty in juvenile females or oestrus synchronization in the adult female colonies. With regard to the chemical nature of the`male primer', literature controversies abound. For example, while the wind tunnel experiment of Whitten et al. (1968) on oestrus induction seems to favour the notion of the pheromone's volatility, Vandenbergh and co-workers (Vandenbergh 1969; Vandenbergh et al. 1975 Vandenbergh et al. , 1976 , in their studies using the uterine weight assays (puberty acceleration), strongly advocate the idea that the pheromone is a large and/or non-volatile molecule, such as a protein or peptide. Although a rational argument has been made by Bronson & MacMillan (1983) that both the oestrus synchronization and puberty acceleration have the same endocrinological denominator, it has never been resolved whether the same chemosignal causes both e¡ects.
In spite of a certain amount of progress in our understanding of the chemical nature of endocrinologically dependent urinary volatiles in the house mouse (Novotny et al. , 1990a Schwende et al. 1986 ) and the endocrinological and behavioural e¡ects caused by the synthetic analogues of these compounds (Novotny et al. , 1990a Jemiolo et al. 1986 )öall apparently small moleculesöa relatively recent report (Mucignant-Caretta et al. 1995) attributes the male-to-female puberty acceleration activity to a urinary protein and/or its N-terminal hexapeptide. This so-called major urinary protein (MUP) is, in fact, a conglomerate of polypeptide isoforms (Finlayson et al. 1965) , all having molecular mass of less than 20 kD. MUP is apparently under testosterone control, being expressed predominantly in adult males. The points relative to the question of pheromones' volatility are that (i) in spite of repeated puri¢cations and lyophilization steps, the fractions biologically active in the uterine weight assays (Vandenbergh et al. 1975; Novotny et al. 1980) continue to possess an odour reminiscent of mouse urine; and (ii) even after extensive purging of the unfractionated urine for many hours, the samples retain their odour, their capability of`yielding' numerous volatile organic molecules and their biological activity (Novotny et al. 1980 .
Here, we provide evidence that ¢ve out of the six volatile organic molecules with a strong a¤nity to MUP are individually active in the uterine weight bioassays. Moreover, neither a recombinant MUP, nor the hexapeptide with the alleged (Mucignant-Caretta et al. 1995) biological activity, can themselves promote uterine growth in juvenile female mice. Interestingly, the synthetic analogues of certain mouse volatile chemosignals (namely, 3,4-dehydro-exo-brevicomin (DB), 2-sec-butyl-4, 5-dihydrothiazole (BT), and a-and b-farnesene), all exhibiting this biological activity and a strong a¤nity to MUP, were previously implicated in oestrus synchronization (Jemiolo et al. 1986; Ma et al. 1999) . This communication thus supports Bronson's opinion (Bronson & MacMillan 1983 ) that puberty acceleration in juvenile females and oestrus synchronization in an adult female colony are likely to be caused by the same maleoriginated chemosignal. As discussed below, there are several possible advantages of a system where the active pheromone is ligated to a larger and less volatile carrier molecule, such as MUP of the house mouse. 
MATERIALS AND METHODS

(a) Experimental animals and testing procedures
Adult ICR (albino) mice, originated from Harlan/SpragueD awley, Inc. (Indianapolis, IN), were bred to produce all litters. The pregnant females were isolated in individual cages one week prior to parturition. After birth, each litter was counted and sexed, adjusting the litter size to ten, with a sex ratio of 7:3 (female:male). After weaning at day 21, juvenile females were weighed and assigned randomly to di¡erent experimental groups, with each group receiving a di¡erent olfactory stimulus or an appropriate control solution. Each experimental group was placed in a separate room. Animals were singly or doubly caged (every group had three to four cages each occupied by two mice). All animals were housed in polypropylene cages with opaque sides and ¢tted wire-lids (12 cm Â 27 cm Â17 cm). A wood-shaving bedding was changed once per week. Food and water were provided ad libitum. All rooms were maintained at 21^22 8C, 70% relative humidity and 12 L:12 D lighting regime, with lights on at 06.00.
Each experimental treatment of the juvenile females was begun at day 21 and continued for six consecutive days. Each experimental mouse was treated twice daily (09.00^10.00; 16.00^17.00) on the nasal groove and external nares with a 30 ml solution of an appropriate experimental substance, through a small plastic tube adapted to a microsyringe. Separate microsyringes were used for di¡erent treatment groups. At day 27, the mice were weighed again and sacri¢ced by cervical dislocation. Their uteri were removed, trimmed from surrounding tissue and weighed on the analytical balance. The uterine weight was used as an index for the pheromonal (puberty acceleration) activity. The data were evaluated through the one-way analysis of variance (ANOVA) (Zar 1984) . To overcome the distribution problem, the data were log transformed prior to their statistical analysis (Vandenbergh et al. 1975) .
To accommodate a large number of experimental groups into our animal facility (each experimental group occupying a separate room), two separate trials were conducted at di¡erent times (experiment 1: June 1996; experiment 2: October 1996). In experiment 1, 46 adult females were mated to produce progeny. Only the pups with a body weight ranging from 12.5^14.8 g (at weaning) were chosen. Eight treatment groups (on average, 20 animals for each treatment, with the exact numbers speci¢ed below) were set to test an e¡ect of the following stimuli: (i) a mixture of DB and BT (at 1.3 ppm concentration in water), 20 animals; (ii) a mixture of the same compounds, dissolved at 1.3 ppm in the urine of castrated adult males, 19 animals; (iii) a newly found, unique male urinary component, 6-hydroxy-6-methyl-3-heptanone , dissolved in water at 2000 ppm level, 19 animals; (iv) the MUP complex (19 animals), isolated from the urine of adult male mice through a Sephadex G50 column and reconstituted in water (after lyophilization) to its natural concentration (4 mg ml À1 , as assayed by UV absorbance at 280 nm); (v) a hexapeptide N-Glu-Glu-AlaArg-Ser-Met (dissolved at 500 mg ml À1 ), 23 animals; (vi) adult male urine, used as a positive control (20 animals); and (vii) water used as a conventional control (20 animals). In experiment 2, 63 adult females were mated to produce progeny. Only the pups with a body weight from 12.0^14.3 g (at the time of weaning) were selected. They were assigned randomly to ten treatment groups (13^20 animals per treatment), followed by the uterine weight assays: (i) the male MUP, prepared as before (20 animals); (ii) MUP from testosterone-treated females (0.3 mg d À1 dose for ten days prior to urine collection)öthis protein was concentrated to the level of male MUP, as judged by UV absorbance (280 nm) of the protein solution (20 animals); (iii) untreated female MUP (17 animals), concentrated to a comparable protein ultraviolet absorbance (280 nm); (iv) geraniol, dissolved at 10 ppm in water (13 animals); (v) b-farnesene, dissolved in castrate urine at 250 ppm (13 animals); (vi) a mixture of a-and b-farnesene, dissolved in castrate urine at 250 ppm (14 animals); (vii) DB, dissolved in castrate urine at 1.3 ppm (13 animals); (viii) BT, dissolved in castrate urine at 1.3 ppm (13 animals); (ix) water, used as a control (20 animals) for (i), (ii), (iii) and (iv); (x) castrate urine (13 animals), used as a control for (v), (vi), (vii) and (viii).
During September^October 1997, when the recombinant MUP (see below) was prepared for our experiments (Z |¨dek et al. 1999) , 60 additional young females were tested, using the identical procedures as described above, with three di¡erent stimuli: (i) recombinant MUP (4 mg ml À1 , 20 animals); (ii) natural MUP (positive control, 20 animals); and (iii) water (conventional control, 20 animals).
Adult male and female ICR mice were used as urine donors. The urine samples were collected by holding the animals over a clean glass plate and gently pressing the £ank areas. Upon collection, samples were frozen (À20 8C) until used for either MUP isolation or biological testing.
(b) Reagents and analytical methods
Synthetic analogues of the male mouse pheromones (DB, BT, and a-and b-farnesenes) were prepared using the previously described syntheses North & Pattenden 1990; Novotny et al. 1999) . Geraniol was purchased from Sigma (St Louis, MO). The synthesis and properties of a recently identi¢ed 6-hydroxy-6-methyl-3-heptanone are reported elsewhere .
MUP fractions from the normal male and female urinary samples, as well as from testosterone-treated females, were prepared through size-exclusion chromatography on a Sephadex G50 column (60 cm Â 8 mm, internal diameter (i.d.)) and assayed through UV absorbance monitoring. The MUP pro¢les were further checked through a standard polyacrylamide gel electrophoresis (Laemmli 1970) .
The isolated protein fractions (3 ml) were extracted with 0.5 ml aliquots of ether and the extract was further analysed by separating its components on a Rtx-5 (Restek, Bellefonte, PA) column (60 m Â 0.25 mm, i.d.) attached to the electron impact ion source of a Hewlett-Packard 5890 series II mass spectrometer. The separated compounds were structurally identi¢ed from their mass spectra and chromatographic retention coinciding with the data from authentic compounds.
Recombinant MUP-I was expressed in Escherichia coli as described in detail elsewhere (Z |¨dek et al. 1999) . Brie£y, the part of the MUP-1 gene (cLiv1 clone, provided by J. Bishop, Centre for Genome Research, University of Edinburgh, UK) that encodes the mature protein was cloned into pET-28b(+) plasmid. A factor Xa protease cleavage site incorporated in the N-terminal region provided an easy way to produce a native-like protein. The identity of this protein was veri¢ed through the use of matrix-assisted laser desorption/ionization mass spectrometry (Voyager DE TM RP BioSpectrometry TM Work Station, PerSeptive Biosystems, Framingham, MA), yielding the correct mass of 18692 AE 4, an identical tryptic map and an isoelectric point of 4.6 (indistinguishable from the native protein when run in parallel) in a gel system. Measurements of the binding capacity for BTand its total characterization by NMR spectroscopy (Z |¨dek et al. 1999) showed that the protein was prepared in its native form. Moreover, the routine Edman sequencing procedure veri¢ed its terminal residues as N-Glu-Glu-Ala-Ser-SerBThr. N-Glu-GluAla-Arg-Ser-Met was synthesized using Rainin PS3 (Rainin, Woburn, MA) equipment and common chemicals. Its purity was veri¢ed by the reversed-phase high-performance liquid chromatography and determination of its molecular mass (721.78 Da).
RESULTS
The MUP complex isolated from the urine of normal males retained its`mousy' odour in spite of its clear separation from the free low-molecular urinary components on the Sephadex column. However, from the many previously identi¢ed (Schwende et al. 1986; Novotny et al. 1990a,b) urinary volatile constituents, only a few seem selectively retained by MUP (¢gure 1), implicating the structures shown in ¢gure 2 as potential chemosignals.
It has now been well established that the production of MUP in mice is strongly dependent on the androgen levels (Knopf et al. 1983) . Females and castrated males in our experiments produced only a small fraction of the urinary protein isolated from normal, adult males (results not shown); this is in agreement with the earlier observations (Knopf et al. 1983 ) and a corresponding substantial decrease of the above volatile constituents. However, a repeated treatment of female mice with testosterone increased the MUP fraction to the level comparable to normal males (results not shown). The corresponding gas chromatogram indicated that the hydroxy ketone^lactol and DB urinary concentrations were also brought to the range associated with the normal male. Interestingly, only a trace of geraniol and no detectable amount of BT were observed in the androgenized females or testosteronetreated castrates. The MUP isolated from testosteronetreated females had a strong odour reminiscent of the male mouse urine.
Two independent trials, employing both the natural stimuli and treatments with synthetic compounds (applied individually or in certain mixtures), demonstrate statistically signi¢cant increases in the uterine weight for several cases (¢gure 3a,b): MUP isolated from the normal males and testosterone-treated females were both e¡ec-tive, as was the aqueous solution of 6-hydroxy-6-methyl-3-heptanone ). To our surprise, DB and BT (applied individually or in a mixture dissolved in either the castrate urine or plain water), and both farnesene isomers were also found to be e¡ective. Geraniol was the only component binding to the MUP complex that was found inactive in the uterine weight assays.
The tested levels of synthetic ligands is justi¢ed by the fact that (i) lactol concentrations between 630 and 1820 ppm were observed in the randomly collected male urine pools ; (ii) the farnesenes are non-polar compounds with a relatively poor solubility in water, and their urinary and preputial gland concentrations are far greater than what has been seen in ¢gure 1; (iii) geraniol, a structural`relative' of the farnesenes with an alcohol functionality, is more soluble in water, making the losses through manipulation less likely than for the farnesenes; and (iv) the levels of BT and DB chosen were similar to those potentiating oestrus synchronization in our earlier work (Jemiolo et al. 1986) . Table 1 shows the results comparing the e¡ect of natural MUP with r-MUP I, a protein overexpressed in E. coli which is structurally identical to one of the major components of the natural MUP complex in terms of its exact mass, sequence and the binding behaviour towards BT (Z |¨dek et al. 1999) . Unlike the MUP isolated from the male mouse urine, the recombinant protein had no characteristic odour and was devoid of any volatiles during a GC^MS analysis. These results indicate the lack of shows as the large peak, the small peaks designated with the same letter are its degradation products, dihydrofurans ; DB, 3,4-dehydro-exo-brevicomin; BT, 2-sec-butyl-4, 5-dihydrothiazole; G, geraniol; b, b-farnesene; a, a-farnesene. The unlabelled trace peaks are contaminants from distilled water and bu¡ers. Figure 2 . Chemical structures of (a) (S)-2-sec-butyl-4, 5-dihydrothiazole; (b) (R,R)-3,4-dehydro-exo-brevicomin; (c) E,E-a-farnesene; (d) E-b-farnesene; (e) 6-hydroxy-6-methyl-3-heptanone and its equilibrium cyclic form; and ( f ) geraniol.
biological activity for the recombinant protein. Additionally, the hexapeptide, alleged to be biologically active in the report from a di¡erent group (Mucignant-Caretta et al. 1995) , had no e¡ect on the uterine weight (¢gure 3).
At the beginning of treatments (day 21), the body weights were recorded for all experimental animals, and once again, on day 27. Statistical analyses indicated that there were no di¡erences among treatments within each experimental set either for the body weight at day 21 or day 27 (p40.05). Due to a seasonal in£uence, the animals in experiment 1 had slightly higher body weights on both day 21 and day 27 than those in the other experiments. This may have contributed to the tendency for slightly larger uterine weights in experiment 1. Due to the limitation of space, the treatment experiments in the second set had to be conducted with two female mice per cage. We have, however, veri¢ed independently (results not shown) that there was no statistically signi¢cant di¡erence between the singly and doubly caged mice in the times for vaginal opening, oestrus induction and uterine weights under the described conditions.
DISCUSSION
The urinary proteins excreted by various rodents represent an intriguing class of biomolecules. They belong to the general class of lipocalins, small proteins with the capability of binding a variety of relatively hydrophobic ligands (Flower 1996) . The MUP of the house mouse is a complex of protein isoforms of approximately 18 kD of mass with the proven capacity (Novotny et al. 1980 Robertson et al. 1993) for binding low-molecular weight entities, including two volatile substances with a proven primer e¡ect of oestrus synchronization (Jemiolo et al. 1986 ). The advantages of such a ligand^protein complexation may include a slow release Robertson et al. 1998 ) of volatile chemosignals into the environment, protection of a labile pheromone and perhaps even a proper delivery of pheromones to the site of reception (if the mice engage in a direct physical contact with the main source of chemosignal, such as urine). These are all equilibrium-driven situations.
The widespread notion that MUPs are the pheromones themselves can be challenged on several grounds: (i) even though the protein fraction from the mouse urine is active in the uterine weight bioassays (Mucignant-Caretta et al. 1995; Novotny et al. 1980 Novotny et al. , 1999 , its strong odour and instrumentally measurable content of volatiles cannot be ignored; (ii) BT and DB, the molecules implicated in oestrus synchronization (Jemiolo et al. 1986) , attractiveness to females and intermale aggression , bind strongly to MUP; and (iii) DB was recently found as a ligand facilitating transmembrane signalling (Moss et al. 1997 ) in a receptive neuron (from vomeronasal organ). The results shown in this communication clarify further the relationship between MUP and its volatile ligands.
As seen in ¢gure 1, several biochemically and physiologically relevant ligands bind to the male-originated MUP: BT and DB, two components with a previously shown chemosignalling function (Novotny et al. , 1990a Jemiolo et al. , 1986 ; a-and b-farnesene, two terpenoid isomers related to an intermediate in the steroid biosynthetic pathway (Stryer 1995) , which are further known to signal dominance among males (Novotny et al. 1990b) , be attractive to females (Jemiolo et al. 1991) and promote oestrus synchronization ; and 6-hydroxy-6-methyl-3-heptanone, a compound with a recently proven puberty-accelerating activity . Geraniol is an odoriferous, terpenic substance (Budavari 1996) BT was absent, suggesting a testicular control of biosynthesis or excretion of the latter. The individually tested synthetic analogues of the ligands binding to MUP brought a most surprising result: in spite of their very di¡erent chemical structures, they were all capable of enhancing the uterine weight (while tested individually or in mixtures) to the level statistically comparable to the e¡ect of the whole urine or the natural (isolated) MUP. In fact, the only substance lacking this activity was geraniol. The overall biological activity is attributable to the combined e¡ects of these ligands, whether bound to MUPs or in their dissociated forms.
It is noteworthy that the farnesenes have a di¡erent glandular source from the rest of the urinary components binding to MUP. They are the most conspicuous components of the mouse preputial gland, while the remaining substances originate from the bladder urine (Novotny et al. 1990b ). Whether or not the farnesene^MUP complex is assembled already in the preputial secretion or in the voided urine is currently unknown. Importantly, the fact that both the farnesenes and the bladder-originated volatile ligands are active in puberty acceleration could help resolve yet another long-term controversy in the literature pertaining to a source of the oestrus-inducing chemosignal (Chipman & Albrecht 1974; . We have previously found that a mixture of BT with DB in water (Jemiolo et al. 1986 ) and a mixture of a-and b-farnesene are both active in oestrus induction. This fact, combined with their activity in the uterine weight assays shown here, supports the argument made earlier by Bronson & MacMillan (1983) that puberty acceleration in juvenile females and oestrus synchronization in adult animals should have the same endocrinological denominator and thus, similar chemosignal(s).
The recombinant MUP, devoid of the volatile ligands, has no biological activity (table 1). The same was found to be true for the MUP-associated (N-terminal) hexapeptide, claimed previously (by Mucignant-Caretta et al. 1995) as active. It should also be noted that this terminal sequence is atypical for the naturally found MUPs; it might have been intentionally chosen as a possible (pseudo) gene product. The absence of biological response to recombinant MUP-1 is the most compelling argument for the key role of volatile ligands. The results of Vandenbergh et al. (1975) and perhaps those of MucignantCaretta et al. (1995) (using di¡erent methodologies and animal strains) can be explained by the complexation of pheromones with MUPs and persistence of the complexed form even after exhaustive extraction of the urinary material with organic solvent. The active pheromones seem to occur in at least three urinary fractions: (i) as bound to MUP; (ii) in the peptide-containing fractions following MUP ; and (iii) as free ligands. The work towards understanding of the physical causes of complexation for all individually identi¢ed chemosignals is in progress.
